In this respect, we can speculate that the administration of anti-PDL1/2 Abs soon after CTX injection benefits from all these “off target” mechanisms and boosts tumor-specific immune responses before the immune-stimulating effect of the drug is exhausted. Here, CD274 is linked to neoplasm.